AIM
EW icon

Arcadia Investment Management’s Edwards Lifesciences EW Stock Holding History

Arcadia Investment Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$881 Hold
11
– – ﹤0.01% 265
2025
Q4 		$938 Buy
+11
New +$903 ﹤0.01% 271
2016
Q3 		– Sell
-891
Closed -$30K – 367
2016
Q2 		$30K Buy
+891
New +$30.5K 0.01% 265

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Arcadia Investment Management's EW Position: Q1 2026 in Review

Arcadia Investment Management held its Edwards Lifesciences (EW) position steady in Q1 2026 at 11 shares worth $881. The position accounts for ﹤0.01% of the portfolio, ranked #265.

Arcadia Investment Management first reported a position in EW in Q2 2016 and has held it in 3 quarters since. The position peaked at $30K in Q2 2016. 1,287 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Arcadia Investment Management held 11 shares of Edwards Lifesciences worth $881 as of Q1 2026.
  • Arcadia Investment Management left its Edwards Lifesciences share count unchanged in Q1 2026.
  • Edwards Lifesciences made up ﹤0.01% of Arcadia Investment Management's portfolio in Q1 2026, its #265 holding.
  • Arcadia Investment Management first reported a position in Edwards Lifesciences in Q2 2016 and has held it in 3 quarters since.
  • Arcadia Investment Management's Edwards Lifesciences position peaked at $30K in Q2 2016.
  • 1,287 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Arcadia Investment Management's 13F filing for Q1 2026, filed 22 Apr 2026.